244 In the index

Lorcaserin LORC

A weight-loss drug (Belviq) that was FDA-approved before being pulled from the market. It did help people lose weight in trials, but a required long-term safety study found it was linked to a higher rate of cancer diagnoses, leading regulators to ask for its withdrawal.

Also known as Belviq

Effects Lose fat

Routes Oral

Legal status Unapproved / investigational

WADA Not listed

3D Molecular Structure of C₁₁H₁₄ClN

Drag to rotate · scroll to zoom

Chemistry

Formula: C11H14ClN
Molar mass: 195.69
CAS: 616202-92-7
PubChem CID: 11658860

Reported dosing

Limited data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 10 mg twice daily

Reported range 10 mg twice daily (standard, discontinued formulation)

Route Oral

Frequency Twice daily

Duration Was intended for chronic use before market withdrawal

Was FDA-approved (Belviq) for weight management but voluntarily withdrawn from the US market in 2020 after trials showed an increased cancer signal. No longer legally available in the US.

Where this comes from FDA prescribing information (withdrawn); post-marketing safety trial data

Human data for this compound is limited. Read the figures above as a record of reported use rather than established dosing.